0001209191-24-005001.txt : 20240320
0001209191-24-005001.hdr.sgml : 20240320
20240320172200
ACCESSION NUMBER: 0001209191-24-005001
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240318
FILED AS OF DATE: 20240320
DATE AS OF CHANGE: 20240320
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: LEVIN JEREMY M
CENTRAL INDEX KEY: 0001256153
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38085
FILM NUMBER: 24768650
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Ovid Therapeutics Inc.
CENTRAL INDEX KEY: 0001636651
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 465270895
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 441 NINTH AVENUE, 14TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10001
BUSINESS PHONE: 212-776-4381
MAIL ADDRESS:
STREET 1: 441 NINTH AVENUE, 14TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10001
4
1
doc4.xml
FORM 4 SUBMISSION
X0508
4
2024-03-18
0
0001636651
Ovid Therapeutics Inc.
OVID
0001256153
LEVIN JEREMY M
C/O OVID THERAPEUTICS INC.
441 NINTH AVENUE
NEW YORK
NY
10001
1
1
0
0
CEO
0
Common Stock
2024-03-18
4
P
0
18248
2.76
A
3616715
D
Common Stock
35461
I
See Footnote
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.76 to $2.78 inclusive. The reporting person undertakes to provide to Ovid Therapeutics Inc., any security holder of Ovid Therapeutics Inc., or staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Footnote 1 to this Form 4.
The reportable securities are owned directly by Divo Holdings, LLC ("Divo"). The Reporting Person's spouse is the manager of Divo. The Reporting Person disclaims beneficial ownership of the shares held by Divo and this report shall not be deemed an admission of beneficial ownership of such shares for the purposes of Section 16 or for any other purpose.
/s/ Danielle Mann for Jeremy M. Levin by PoA
2024-03-20